Erythroid differentiation intensifies RNA mis-splicing in SF3B1-mutant myelodysplastic syndromes with ring sideroblasts

Myelodysplastic syndromes with ring sideroblasts (MDS-RS) commonly originate from mutations in the splicing factor SF3B1 (SF3B1mt). SF3B1mt cause RNA mis-splicing, mechanistically established as the major driver of RS development. However, little is known about RS fate and biology after their initial formation in the human bone marrow. We here achieve isolation of viable RS from patient samples, enabling the first complete investigation of SF3B1mt development from stem cell to RS. We show that RS skew MACS-isolated CD34+ data towards erythroid features not recapitulated in single-cell RNAseq. We demonstrate that RS divide, differentiate, enucleate and actively respond to mis-splicing/oxidative stress, decreasing wildtype stem cell fitness via GDF15 overproduction. We identify circulating RS as a uniform clinical feature associated with disease burden. Finally, we establish that SF3B1mt mis-splicing intensifies during erythroid differentiation and demonstrate through combined transcriptomics/proteomics an uncoupling of RNA/protein biology in RS encompassing severe and dysfunctional mis-splicing of proapoptotic genes. Statement of significance We here combine a novel method for RS isolation with state-of-the-art multiomics to perform the first complete investigation of SF3B1mt MDS-RS hematopoiesis from stem cell to RS. We identify the survival mechanisms underlying SF3B1mt erythropoiesis and establish an active role for erythroid differentiation and RS themselves in SF3B1mt MDS-RS pathogenesis.

[1]  G. Castellani,et al.  Molecular International Prognostic Scoring System for Myelodysplastic Syndromes. , 2022, NEJM evidence.

[2]  P. Woll,et al.  Long-Term Clonal Inversion in an MDS-RS Case with Dual SF3B1 Mutations , 2022, Blood.

[3]  R. Sandberg,et al.  Scalable single-cell RNA sequencing from full transcripts with Smart-seq3xpress , 2022, Nature Biotechnology.

[4]  M. Cazzola,et al.  Patient-specific MDS-RS iPSCs define the mis-spliced transcript repertoire and chromatin landscape of SF3B1-mutant HSPCs , 2022, Blood advances.

[5]  P. Campbell,et al.  The longitudinal dynamics and natural history of clonal haematopoiesis , 2021, Nature.

[6]  J. Abkowitz,et al.  Coordinated missplicing of TMEM14C and ABCB7 causes ring sideroblast formation in SF3B1-mutant myelodysplastic syndrome , 2021, Blood.

[7]  P. Woll,et al.  Integrative Analysis of Primary SF3B1 mt Ring Sideroblasts Provides Fundamental Insights into MDS-RS Pathogenesis and Dyserythropoiesis , 2021, Blood.

[8]  T. Haferlach,et al.  Splicing factor gene mutations in acute myeloid leukemia offer additive value if incorporated in current risk classification. , 2021, Blood advances.

[9]  J. George,et al.  Poison Exon Splicing Regulates a Coordinated Network of SR Protein Expression during Differentiation and Tumorigenesis. , 2020, Molecular cell.

[10]  R. Sandberg,et al.  Single-cell RNA counting at allele and isoform resolution using Smart-seq3 , 2019, Nature Biotechnology.

[11]  R. Rabadán,et al.  Disease-Causing Mutations in SF3B1 Alter Splicing by Disrupting Interaction with SUGP1. , 2019, Molecular cell.

[12]  B. Sander,et al.  A three-dimensional in vitro model of erythropoiesis recapitulates erythroid failure in myelodysplastic syndromes , 2019, Leukemia.

[13]  R. Margueron,et al.  A variant erythroferrone disrupts iron homeostasis in SF3B1-mutated myelodysplastic syndrome , 2019, Science Translational Medicine.

[14]  S. Ogawa.  Genetics of MDS. , 2019, Blood.

[15]  M. Cazzola,et al.  Aberrant splicing and defective mRNA production induced by somatic spliceosome mutations in myelodysplasia , 2018, Nature Communications.

[16]  Erik Sundström,et al.  RNA velocity of single cells , 2018, Nature.

[17]  Hongyan Ni,et al.  Iron overload impairs normal hematopoietic stem and progenitor cells through reactive oxygen species and shortens survival in myelodysplastic syndrome mice , 2018, Haematologica.

[18]  Christopher S. Hughes,et al.  Extending the Compatibility of the SP3 Paramagnetic Bead Processing Approach for Proteomics. , 2018, Journal of proteome research.

[19]  Satoru Miyano,et al.  Gene expression and risk of leukemic transformation in myelodysplasia. , 2017, Blood.

[20]  S. Swerdlow.  WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues , 2017 .

[21]  T. Haferlach,et al.  Molecular analysis of myelodysplastic syndrome with isolated deletion of the long arm of chromosome 5 reveals a specific spectrum of molecular mutations with prognostic impact: a study on 123 patients and 27 genes , 2017, Haematologica.

[22]  M. Moarii,et al.  SF3B1-initiating mutations in MDS-RSs target lymphomyeloid hematopoietic stem cells. , 2017, Blood.

[23]  Sara E. Meyer.  Splicing together the origins of MDS-RS. , 2017, Blood.

[24]  M. Konopleva,et al.  An exploratory clinical trial of bortezomib in patients with lower risk myelodysplastic syndromes , 2017, American journal of hematology.

[25]  J. Aerts,et al.  SCENIC: Single-cell regulatory network inference and clustering , 2017, Nature Methods.

[26]  Peter Bankhead,et al.  QuPath: Open source software for digital pathology image analysis , 2017, Scientific Reports.

[27]  Michelle C. Chen,et al.  Physiologic Expression of Sf3b1(K700E) Causes Impaired Erythropoiesis, Aberrant Splicing, and Sensitivity to Therapeutic Spliceosome Modulation. , 2016, Cancer cell.

[28]  R. Kusec,et al.  Cryptic splicing events in the iron transporter ABCB7 and other key target genes in SF3B1-mutant myelodysplastic syndromes , 2016, Leukemia.

[29]  Mario Cazzola,et al.  The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. , 2016, Blood.

[30]  M. Warmuth,et al.  Cancer-Associated SF3B1 Hotspot Mutations Induce Cryptic 3' Splice Site Selection through Use of a Different Branch Point. , 2015, Cell reports.

[31]  N. Kadowaki,et al.  The role of growth differentiation factor 15 in the pathogenesis of primary myelofibrosis , 2015, Cancer medicine.

[32]  J. Kere,et al.  Aberrant splicing of genes involved in haemoglobin synthesis and impaired terminal erythroid maturation in SF3B1 mutated refractory anaemia with ring sideroblasts , 2015, British journal of haematology.

[33]  M Cazzola,et al.  Disruption of SF3B1 results in deregulated expression and splicing of key genes and pathways in myelodysplastic syndrome hematopoietic stem and progenitor cells , 2014, Leukemia.

[34]  Jie Li,et al.  Global transcriptome analyses of human and murine terminal erythroid differentiation. , 2014, Blood.

[35]  R Core Team,et al.  R: A language and environment for statistical computing. , 2014 .

[36]  C. Weiser,et al.  Incomplete cytokinesis and re-fusion of small mononucleated Hodgkin cells lead to giant multinucleated Reed–Sternberg cells , 2013, Proceedings of the National Academy of Sciences.

[37]  M. Cazzola,et al.  Diagnosis and treatment of primary myelodysplastic syndromes in adults: recommendations from the European LeukemiaNet. , 2013, Blood.

[38]  N. Taylor,et al.  Isolation and functional characterization of human erythroblasts at distinct stages: implications for understanding of normal and disordered erythropoiesis in vivo. , 2013, Blood.

[39]  M. Cazzola,et al.  The transporter ABCB7 is a mediator of the phenotype of acquired refractory anemia with ring sideroblasts , 2013, Leukemia.

[40]  Johannes E. Schindelin,et al.  Fiji: an open-source platform for biological-image analysis , 2012, Nature Methods.

[41]  S. Sugano,et al.  Frequent pathway mutations of splicing machinery in myelodysplasia , 2011, Nature.

[42]  M. Cazzola,et al.  Ring sideroblasts and sideroblastic anemias , 2011, Haematologica.

[43]  C. Beaumont,et al.  Missense SLC25A38 variations play an important role in autosomal recessive inherited sideroblastic anemia , 2011, Haematologica.

[44]  T. S. St. Pierre,et al.  Magnetic susceptibility of iron in malaria-infected red blood cells. , 2009, Biochimica et biophysica acta.

[45]  M. Docquier,et al.  Growth differentiation factor 15 production is necessary for normal erythroid differentiation and is increased in refractory anaemia with ring‐sideroblasts , 2009, British journal of haematology.

[46]  Vladimir Vacic,et al.  Two Sample Logo: a graphical representation of the differences between two sets of sequence alignments , 2006, Bioinform..

[47]  Bengt Fadeel,et al.  Apoptosis in refractory anaemia with ringed sideroblasts is initiated at the stem cell level and associated with increased activation of caspases , 2001, British journal of haematology.

[48]  J. Lindemans,et al.  Influence of iron deficiency anaemia on haemoglobin A2 levels: possible consequences for beta-thalassaemia screening. , 1999, Scandinavian journal of clinical and laboratory investigation.

[49]  J. Higginson,et al.  International Agency for Research on Cancer. , 1968, WHO chronicle.